Ascendis Pharma Revenue (TTM) Analysis

Ascendis Pharma AS (ASND)

129.81 +7.17 (+5.85%) USD | NASDAQ | Nov 22, 16:00

134.49 +4.68 (+3.61%) After-Hours: 20:00

Revenue (TTM) Chart

Historical Revenue (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
September 30, 2024	354.82M
June 30, 2024	343.51M
March 31, 2024	356.43M
December 31, 2023	288.35M
September 30, 2023	163.47M
June 30, 2023	126.57M
March 31, 2023	81.45M
December 31, 2022	53.04M
September 30, 2022	35.23M
June 30, 2022	21.14M
March 31, 2022	15.81M
December 31, 2021	9.044M
September 30, 2021	4.081M
June 30, 2021	5.993M
March 31, 2021	6.342M
December 31, 2020	7.899M
September 30, 2020	10.04M
June 30, 2020	9.307M
March 31, 2020	11.33M
December 31, 2019	15.03M
September 30, 2019	24.25M

Date	Value
June 30, 2019	21.78M
March 31, 2019	18.19M
December 31, 2018	12.08M
September 30, 2018	0.4089M
June 30, 2018	0.8958M
March 31, 2018	1.363M
December 31, 2017	1.725M
September 30, 2017	2.520M
June 30, 2017	3.315M
March 31, 2017	4.110M
December 31, 2016	5.101M
September 30, 2016	6.139M
June 30, 2016	7.187M
March 31, 2016	8.051M
December 31, 2015	9.011M
September 30, 2015	10.38M
June 30, 2015	12.33M
March 31, 2015	15.55M
December 31, 2014	18.68M
September 30, 2014	22.71M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

4.081M

Minimum

Sep 2021

356.43M

Maximum

Mar 2024

95.94M

Average

18.47M

Median

Revenue (TTM) Benchmarks